US Physical Therapy (USPH) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $81.95 --0%
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
US Physical Therapy (NYSE: USPH) reported Q2 EPS of $0.81, $0.11 better than the analyst estimate of $0.70. Revenue for the quarter came in at $197.34 million versus the consensus estimate of $189.66 million.
For earnings history and earnings-related data on US Physical Therapy (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
- Cingulate posts wider Q2 loss as SG&A spending more than doubles
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
